v3.26.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Sep. 26, 2026
Dec. 27, 2025
Current assets:    
Cash and cash equivalents $ 200,381 $ 213,770
Trade receivables and contract assets, net of allowances for credit losses of $10,511 and $10,463, respectively 735,305 708,856
Inventories 319,638 299,103
Prepaid assets 97,265 96,108
Other current assets 182,439 129,212
Total current assets 1,535,028 1,447,049
Property, plant and equipment, net 1,497,335 1,655,219
Venture capital and strategic equity investments 194,521 206,972
Operating lease right-of-use assets, net 332,330 361,415
Goodwill 3,084,112 2,764,253
Intangible assets, net 238,662 339,995
Deferred tax assets 67,467 67,334
Other assets 502,052 293,185
Total assets 7,451,507 7,135,422
Current liabilities:    
Accounts payable 144,507 148,800
Accrued compensation 225,937 268,854
Deferred revenue 204,204 210,418
Accrued liabilities 285,737 270,085
Other current liabilities 228,873 222,158
Total current liabilities 1,089,258 1,120,315
Long-term debt, net and finance leases 2,443,461 2,136,360
Operating lease right-of-use liabilities 405,351 434,048
Deferred tax liabilities 81,815 95,203
Other long-term liabilities 156,356 138,302
Total liabilities 4,176,241 3,924,228
Commitments and contingencies (Notes 2, 12, 14, and 16)
Redeemable noncontrolling interests 43,173 41,263
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 49,699 shares issued and 47,876 shares outstanding as of September 26, 2026, and 49,217 shares issued and outstanding as of December 27, 2025 497 492
Additional paid-in capital 2,035,124 1,947,301
Retained earnings 1,705,362 1,388,620
Treasury stock, at cost, 1,823 and zero shares, as of September 26, 2026 and December 27, 2025, respectively (323,281) 0
Accumulated other comprehensive loss (190,691) (171,783)
Total Charles River Laboratories International, Inc. equity 3,227,011 3,164,630
Nonredeemable noncontrolling interest 5,082 5,301
Total equity 3,232,093 3,169,931
Total liabilities, redeemable noncontrolling interests and equity $ 7,451,507 $ 7,135,422